Troy Edward Wilson Buys $1.5M of Kura Oncology Inc (KURA) — SEC Form 4, Nov 17, 2026

Open-Market Net Purchase · SEC Form 4
+$1,504,765

Equity position changed by +16.5%

Reporting Owner
TXN 2026-11-16 · FILED 2026-11-17
Equity Position 1.41M sh 1,214,650 → 1,414,650
Equity Change +16.5% shares held after vs before
Filing Lag 1 business day within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2026-11-17
Report Date
2026-11-17
Accession No.
0001193125-26-464166
Accepted At
2026-11-17 00:45 UTC
Reporting Owner
Name Relationship
Troy Edward Wilson CIK 0001589597
Director CEO
Troy Edward Wilson at Kura Oncology Inc Full insider history
Bought (12 mo) $3,855,765
Sold (12 mo) —
More from this insider at Kura Oncology Inc
2026-08-24 Buy +$1,239,000 View
2026-08-17 Buy +$1,112,000 View
2026-03-25 Exercise — View
2026-01-06 Award — View
2025-11-14 Award — View
All filings by this insider at Kura Oncology Inc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF1 2026-11-13 P - Purchase 98,881 A $7.63 +$754,462 534,337 Direct
Common StockF2 2026-11-16 P - Purchase 101,119 A $7.42 +$750,303 635,456 Direct
Non-Derivative Holdings
Title Shares Held Ownership
Common Stock 479,194 Indirect by One Fish Two Fish Revocable Trust
Common Stock 300,000 Indirect by Lorax Charitable Remainder Unitrust
Footnotes (2)
F1
This transaction was executed in multiple trades at prices ranging from $7.47 to $7.79. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Show more
F2
This transaction was executed in multiple trades at prices ranging from $7.27 to $7.73. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Show more
5%+ Holders · 13D/G 5 filers
Other insiders at Kura Oncology Inc
All Kura Oncology Inc insider activity
GET /v1/forms/4/0001193125-26-464166 API docs
View Original SEC Filing